Margin momentum into capex: can Q1's PAT doubling sustain?
Jayaswal Neco heads to result day with a sharp Q1 beat on margins and finance costs. The test now: whether operational leverage holds as the company funds a ₹1.5 MnTPA pellet plant.
Jayaswal Neco enters Q2 FY27 results with a strong operational tailwind from Q1. The headline: net profit nearly doubled to ₹193.92 Cr (up 108.5% YoY from ₹93.02 Cr), driven by a combination of revenue traction and sharp credit deleveraging. Finance costs fell by nearly half, unlocking margin expansion without requiring topline heroics. The Street consensus sits at ₹102.8 fair value (bull case ₹114.3; Bajaj Broking targets ₹124), but coverage is light and opinions diverge—one analyst holds at ₹64. At ₹91.4, the stock trades neutral on technicals (RSI 53.8) with modest upside priced in. The critical question for Q2: does the margin bounce from finance cost relief stick, or is it a Q1 anomaly as capex ramp-up begins?
The metrics to watch
~₹2,050–2,150 Cr
In-line with run-rate trajectory; demand stable across iron pellets and specialty steels.
~9–10%
The swing factor. Q1's finance-cost relief may persist, but capex outlays and higher raw material volatility could compress. Watch for commentary on working capital and debt trajectory.
Expected lower
The Q1 halving was driven by early debt repayment from strong FCF. If capex funding draws on cash, costs may tick up slightly.
₹200 Cr+ expected
Pellet plant financial closure achieved (₹1.5 MnTPA straight-grate); equipment orders and site prep will dominate capex. No completion date disclosed yet.
A strong print would be: revenue in-line or above, PAT margin holding above 9%, and management guidance on pellet-plant ramp (timeline, phased capex, funded or equity?). A weak print would be: margin compression below 8% due to raw-material inflation or capex drag, or lack of clarity on capex financing or delivery risks.
Street consensus & valuation debate
Recent filings & corporate actions
1 · Pellet plant financial closure (Oct 1)
₹1.5 MnTPA straight-grate pellet plant has achieved financial closure with full lender approval. The project is now moving into capex and commissioning phase. This is a multi-year project; no COD (commercial operation date) disclosed. Expect management to detail capex phasing and time-to-revenue.
2 · Warrant issuance to Vibrant Enterprises (Oct 6)
Jayaswal Neco allotted 2.24 Cr warrants (₹200 Cr capital raise) to Vibrant Enterprises and partners. This provides equity upside to strategic investors and funds the capex without debt. The 2.26% dilution (on a fully diluted basis) signals confidence in the new-plant economics. Warrant conversion terms and exercise timeline remain to be clarified.
3 · Management transition (Oct 1)
Shri Rana Das appointed as President (Materials Management), replacing Ravi Gudi who resigned in July. This is routine senior-staff churn; no operational red flag. Rana Das joins a stable C-suite during a growth inflection.
4 · Insider trading window closed (Sep 28)
Trading window closed for designated persons ahead of Q2 results, per SEBI regulations. Routine compliance; no unusual insider activity noted.
5 · Ownership stable; FII/DII modest (Sep)
FII stake up 42 bps to 1.32% (Q1 FY27); DII up 47 bps to 0.77%. Promoter unchanged at 55.15%. These are micro-moves; no major hot money or strategic buying yet. The warrant issuance to Vibrant is the real vote of confidence.
What to watch on result day (Oct 16)
Revenue growth trajectory (quarterly run-rate stability), PAT margin durability (the crux—will finance-cost relief hold or compress?), capex guidance and funding plan for the pellet plant, working capital trends, and any commentary on raw-material hedging or supply-chain headwinds. The warrant issuance to Vibrant should be explained in context of capex capital needs. Finally, watch the FY27–28 guidance (if any) to signal management confidence in the new-plant payback and incremental margin uplift.
Jayaswal Neco is at an inflection: Q1's margin beat has attracted analyst interest, but the stock is still pricing a cautious view (RSI neutral, modest 18% consensus upside). The pellet plant is a multi-year value driver, funded and on track. The Q2 result will clarify margin durability, capex timing, and whether the finance-cost tailwind is structural or Q1 noise. A beat on PAT and clear capex roadmap could re-rate the stock toward the ₹102–124 consensus range; miss or margin compression could stall the momentum.